Niederer Kraft Frey advised MVM Partners on its investment in icotec ag.
Icotec is a leading company in the field of innovative spinal tumor implants and is commercialising groundbreaking BlackArmor® Carbon/PEEK products that may offer significant clinical advantages over traditional metal implants in the context of spine oncology, making the full potential of the treatment possibilities available for patients along their journey. The investment by MVM Partners will enable icotec to continue its impressive growth and strengthen its research and development capabilities to expand the portfolio into the underserved indications of spinal infection and osteoporosis.
MVM has been investing in high growth healthcare businesses since 1997. It has a broad, global, investment remit, including medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools and digital health, supported by investment teams in Boston and London.
The NKF team was co-led by Corporate/M&A partner Ulysses von Salis and senior associate Katalin Siklosi, working with associate Manuel Hirlinger and junior associate Norina Frey (all Corporate/M&A).